(Q46715697)

English

Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment

scientific article published in November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

1 reference

based on heuristic

inferred from title

Acute myeloblastic leukemia

1 reference

based on heuristic

inferred from title

Jacques-Olivier Bay

5

object named as

Jacques-Olivier Bay

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

author name string

Didier P Blaise

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Jean Michel Boiron

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Catherine Faucher

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Mohamad Mohty

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Valerie-Jeanne Bardoux

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Virginie Perreau

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Diane Coso

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Arnaud Pigneux

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Norbert Vey

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

104

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

1931-1938

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative conditioning regimens for AML allografts: 30 years later

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first compl

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21418

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21418

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16178004

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46715697&oldid=2127991292"